Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2016/7869174 http://scihub22266oqcxt.onion/10.1155/2016/7869174 C5093265!5093265 !27840760     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27840760 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27840760 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Case+Rep+Pediatr 2016 ; 2016 (ä): 7869174 Nephropedia Template TP {{tp|p=27840760 |t=2016. Mitochondrial Disorder Aggravated by Metoprolol |pdf=|usr=}}{{27840760 }} gab.com Text Mitochondrial Disorder Aggravated by Metoprolol JO: Case Rep Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=27840760 #FOAvip Beta-adrenergic blocking agents or beta-blockers are a class of medications used to treat cardiac arrhythmias and systemic hypertension. In therapeutic dosages, they have known adverse outcomes that can include muscular fatigue and cramping, dizziness, and dyspnea. In patients with mitochondrial disease, these effects can be amplified. Previous case reports have been published in the adult population; however, their impact in pediatric patients has not been reported. We describe a pediatric patient with a mitochondrial disorder who developed respiratory distress after metoprolol was prescribed for hypertension. As the patient improved with discontinuation of medication and no alternative etiology was found for symptoms, we surmise that administration of metoprolol aggravated his mitochondrial dysfunction, thus worsening underlying chest wall weakness. Twit Text FOAVip Mitochondrial Disorder Aggravated by Metoprolol ????Case Rep Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=27840760 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27840760 #FOAvip English Wikipedia <ref>{{Cite pmid|27840760 }}</ref> Mitochondrial Disorder Aggravated by Metoprolol #MMPMID27840760 Samuels C ; Koenig MK ; Hernandez M ; Yadav A ; Mosquera RA Case Rep Pediatr 2016[]; 2016 (ä): 7869174 PMID27840760 show ga Beta-adrenergic blocking agents or beta-blockers are a class of medications used to treat cardiac arrhythmias and systemic hypertension. In therapeutic dosages, they have known adverse outcomes that can include muscular fatigue and cramping, dizziness, and dyspnea. In patients with mitochondrial disease, these effects can be amplified. Previous case reports have been published in the adult population; however, their impact in pediatric patients has not been reported. We describe a pediatric patient with a mitochondrial disorder who developed respiratory distress after metoprolol was prescribed for hypertension. As the patient improved with discontinuation of medication and no alternative etiology was found for symptoms, we surmise that administration of metoprolol aggravated his mitochondrial dysfunction, thus worsening underlying chest wall weakness. äMitochondrial Disorder Aggravated by Metoprolol (epmc).pdf DeepDyve Pubget Overpricing